title: Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
authors.forename: T
authors.initials: T
authors.lastname: Baglin
authors.forename: E
authors.initials: E
authors.lastname: Beacham
mesh_terms: D000368:Aged; D002648:Child; D005169:Factor VIII / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007223:Infant; D007518:Isoantibodies / Q000096:biosynthesis*; D008875:Middle Aged; D012307:Risk Factors; D013997:Time Factors
chemical_list: D007518:Isoantibodies; D005169:Factor VIII